Wednesday, August 21, 2019

J&J Loses Case Over Risperdal Antipsychotic Causing Male Breast Growth

A jury decided Johnson & Johnson must pay a Philadelphia man $2.5 million in damages "for failing to warn that its Risperdal antipsychotic could cause gynecomastia."

Consumer Reports Recommends Against Antipsychotics for Depression

Consumer Reports recommends against antipsychotic "augmentation therapy" for depression. The consumer watchdog magazine finds that the unproven efficacy, harmful side effects, availability of alternatives,...

The Legal and Moral Issues of Drugging Children

Jim Gottstein’s presentation March 29, 2012 at the APA’s Humanistic Division. Mr. Gottstein talks about the the legal and moral issues of the massive number...

Over Ten Thousand Unfiled Claims Against Risperdal Over Breast Growth in Young Boys

Johnson & Johnson is exposed to personal injury and product liability lawsuits over the failure to warn about Risperdal gynecomastia side effects in boys.

Department of Defense Apologizes for Antipsychotic-Related Deaths

The Army Times reports on the Department of Defense's crackdown on off-label antipsychotics in the context of research showing a strong link between antipsychotics,...

“Colorado Responds Slowly to Psychotropic Drug Use Among Foster Kids”

The Denver Post writes "Colorado officials have known since at least 2007 that prescriptions and dosage levels of psychotropic drugs — which also include antidepressants, mood...

Tapering Neuroleptics: Two Year Results

A colleague and I have been tracking individuals who elect to reduce their dose of neuroleptic drug. The two year results are presented here.

Why Disclosure Policies Don’t Discourage Drug Salesmen

From The Chronicle: The practice of pharmaceutical industry payments to academic researchers to help promote their drugs remains widespread. Requiring scientists to disclose their ties...

University of Minnesota Ends Recruiting of Research Subjects on Involuntarily Holds

The University of Minnesota announced a change to its research ethics policies this month after coming under criticism “following the recruitment of a schizophrenia...

Identifying Psychiatric Drugs Leading to Emergency Room Visits

More than ten-percent of adults in the United States are currently prescribed at least one psychiatric medication but there is currently a lack of research on the prevalence of adverse drug events (ADEs) associated with these prescriptions outside of clinical trials.

Addressing Non-Adherence to Antipsychotic Medication: A Harm Reduction Approach

Article in the Journal of Psychiatric and Mental Health Nursing Go to "Addressing Non-Adherence to Antipsychotic Medication: A Harm Reduction Approach"          ...

Psychiatry: We Need a Truth and Reconciliation Commission in Mental Health

My name is Leah Harris and I'm a survivor. I am a survivor of psychiatric abuse and trauma. My parents died largely as a result of terrible psychiatric practice. Psychiatric practice that took them when they were young adults and struggling with experiences they didn’t understand. Experiences that were labeled as schizophrenia. Bipolar disorder. My parents were turned from people into permanent patients. They suffered the indignities of forced treatment. Seclusion and restraint. Forced electroshock. Involuntary outpatient commitment. And a shocking amount of disabling heavy-duty psychiatric drugs. And they died young, from a combination of the toxic effects of overmedication, and broken spirits.

Leading Researchers Critique Current Paradigm for Studying ‘Schizophrenia’ Risk

Re-conceptualizing the Clinical-High-Risk/Ultra-High-Risk Paradigm: A critique and reappraisal

Investigate the Markingson Suicide? Not So Fast, Says University President

Responding to a letter signed by 175 scholars asking for an inquiry into the death of Dan Markingson at the University of Minnesota, the Faculty Senate voted to investigate clinical research at the university. But the university president says the Markingson case will not be part of the investigation. What is he trying to hide?

J&J Fraud Plea Prompts Academics to Regret Participation

Following Johnson & Johnson's record $2.2 billion settlement for criminal marketing — including $1.4 billion related to its marketing of Risperdal, making it one of the...

Arkansas Court Overturns $1.2B Judgment Against J&J

The Arkansas Supreme Court today overturned a $1.2 billion judgment against Johnson & Johnson, ruling that laws requiring companies to properly communicate risks and...

Neuroleptics and Tardive Dyskinesia in Children

There's an interesting February 11, 2014, article on Peter Breggin's website: $1.5 Million Award in Child Tardive Dyskinesia Malpractice. Apparently the individual in Dr. Breggin's paper was diagnosed with autism as a child and was prescribed SSRI's before the age of seven. The SSRI's caused some deterioration in the child's behavior and mental condition, to combat which his first psychiatrist prescribed Risperdal (risperidone). Subsequently a second psychiatrist added Zyprexa (olanzapine) to the cocktail. Both Risperdal and Zyprexa are neuroleptics (euphemistically known in psychiatric circles as antipsychotics), and are known to cause tardive dyskinesia.

Teva to Pay $27.6M to Settle Clozapine False Claims Lawsuit

Teva Pharmaceuticals has agreed to pay $27 million to settle federal and state accusation of false claims regarding the antipsychotic Clozapine, and payments made...

Have You Ever Taken an Experimental Antipsychotic Called Bifeprunox?

In 2004, a patient was given an experimental antipsychotic called bifeprunox and died of hepatorenal failure nine days later. But the sponsor apparently did not investigate the death for three years. In late 2007 the sponsor issued a safety alert and suspended all bifeprunox studies. This is where things get interesting.

Long-acting Injection No Better than Oral Antipsychotic

A study of 5-year outcomes for people taking either an ordinary oral antipsychotic or a long-acting injection of an antipsychotic found no differences between the two.

Service-Users See Long-Term Antipsychotic Use as Compromising Recovery, Review Finds

A new meta-review examines the experiences of antipsychotic drugs use among people diagnosed with a psychotic disorder.

Avoiding Antipsychotic Sedation Can Improve Outcome

Sedation from antipsychotics can be mistaken for negative symptoms as well as increase noncompliance, this study in the African Journal of Psychiatry says, and...

“Do We Have to Wait Until He Kills Himself or Someone Else Before Anyone...

In the "agreement for corrective action" against CAFE study coordinator Jean Kenney last week, the Board of Social Work cited Kenney's failure to respond to "alarming voicemail messages" from family members of Dan Markingson. Presumably, the Board is referring to a message left by his mother, Mary Weiss, which warned, "Do we have to wait until he kills himself or someone else before anyone else does anything?" The failure of Kenney and Stephen Olson to take the warnings of Mary Weiss seriously has been one of the most disturbing aspects of this case. In a deposition for the lawsuit filed by Weiss, Kenney was questioned about her response. Here is an excerpt. (The initial questions come from Gale Pearson, an attorney for Mary Weiss.)

“They Need to be Held Accountable”

Psychiatrists at the University of Minnesota forced a young man into a profitable study of antipsychotic drugs over the objections of his mother, who desperately warned that his condition was deteriorating and that he was in danger of killing himself. On May 8, 2004, Mary Weiss' only son, Dan Markingson, committed suicide. A petition to the governor of Minnesota now asks for an investigation.

Glucose Metabolism “Derangements” from Second Generation Antipsychotics Clarified

New Zealand and Chinese investigators believe they have clarified the mechanisms by which second generation antipsychotics cause serious "derangements" in glucose metabolism in the...

Follow Us